US Bancorp
DTIL icon

US Bancorp’s Precision BioSciences DTIL Stock Holding History

US Bancorp’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-89
Closed -$8K – 4109
2022
Q1 		$8K Sell
89
-30
-25% -$4.08K ﹤0.01% 3446
2021
Q4 		$26K Buy
119
+14
+13% +$3.91K ﹤0.01% 2968
2021
Q3 		$37K Buy
105
+3
+3% +$1.02K ﹤0.01% 2796
2021
Q2 		$38K Buy
102
+13
+15% +$3.9K ﹤0.01% 2799
2021
Q1 		$28K Hold
89
– – ﹤0.01% 2867
2020
Q4 		$22K Buy
89
+18
+25% +$4.41K ﹤0.01% 2872
2020
Q3 		$13K Sell
71
-24
-25% -$4.77K ﹤0.01% 2976
2020
Q2 		$24K Sell
95
-71
-43% -$15.5K ﹤0.01% 2731
2020
Q1 		$30K Buy
166
+133
+403% +$34.8K ﹤0.01% 2578
2019
Q4 		$14K Buy
33
+16
+94% +$5.03K ﹤0.01% 2999
2019
Q3 		$4K Buy
+17
New +$5.53K ﹤0.01% 3275

Other funds holding DTIL

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

US Bancorp's DTIL Position: Q2 2022 in Review

US Bancorp sold out of Precision BioSciences (DTIL) in Q2 2022, closing a stake of 89 shares — an estimated $8K sold.

US Bancorp first reported a position in DTIL in Q3 2019 and held it in 11 quarters. The position peaked at $38K in Q2 2021. 119 funds tracked by Wall St. Rank hold DTIL as of Q2 2022.

  • US Bancorp reported no remaining Precision BioSciences position as of Q2 2022 after selling out during the quarter.
  • US Bancorp sold 89 Precision BioSciences shares in Q2 2022, an estimated $8K.
  • US Bancorp first reported a position in Precision BioSciences in Q3 2019 and held it in 11 quarters.
  • US Bancorp's Precision BioSciences position peaked at $38K in Q2 2021.
  • 119 funds tracked by Wall St. Rank held Precision BioSciences as of Q2 2022.

Based on US Bancorp's 13F filing for Q2 2022, filed 1 Aug 2022.